Biotech Values

[DewDiligence]

Tidbit from a 1996 write-up on Copaxone:

http://www.thepharmaletter.com/file/85769/first-approval-of-tevas-ms-drug-copaxone.html

First Approval Of Teva's MS Drug Copaxone

25 November 1996

…Interestingly, there is little intellectual property protection on Copaxone, which was originally developed in the 1960s. Teva has applied for orphan drug status in the USA, which will give it seven year's marketing exclusivity.